Arovella Therapeutics Ltd
F:E4NA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arovella Therapeutics Ltd
F:E4NA
|
AU |
|
Fidia SpA
MIL:FDA
|
IT |
|
P
|
Phibro Animal Health Corp
F:PB8
|
US |
|
A
|
Adx Energy Ltd
XMUN:GHU
|
AU |
|
Technip Energies NV
F:68F
|
FR |
Intrinsic Value
Is E4NA undervalued or overvalued?
See the intrinsic value estimate for 
Arovella Therapeutics Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
E4NA looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with E4NA’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Arovella Therapeutics Does
Arovella Therapeutics is a biotechnology company that develops cancer cell therapies. Its work centers on engineered immune cells, especially invariant natural killer T, or iNKT, cells, which are designed to recognize and attack cancer cells more effectively than the body’s natural defenses. The company’s main job is to turn early-stage scientific research into drug candidates that can be tested in patients.
- Headquarters
- Australia AU
- IPO date
- Jan 24, 2002
Earnings Waterfall
Arovella Therapeutics Ltd
The intrinsic value for Arovella Therapeutics Ltd (E4NA) under the Base Case is hidden EUR.
Compared with the current market price of 0.028 EUR, the stock appears hidden.